The Venture Codex Logo

The Venture Codex

Krohne

Ludwig-Krohne-Straße 5, Duisburg, Nordrhein-Westfalen, 47058, Germany

Overview

A world-leading manufacturer and supplier of solutions in industrial process instrumentation.

Total investments
1
Lead investments
0
Investments · 12mo
0
Active investors
0

Sector focus

  • Industrial
  • Manufacturing
Visit website

Investment portfolio

  • Aizon

    Participated · Seed · Dec 2017

    Aizon is an AI SaaS provider that transforms pharmaceutical manufacturing operations with a GMP-compliant predictive analytics and smart factory platform. Its offering combines industrialized AI and a contextualized Historian to deliver predictive analytics, optimization, and enhanced decision-making for pharma manufacturers. Aizon emphasizes rigorous quality and compliance, following GAMP5 for GMP processes to ensure compliant data acquisition, storage, and consumption. The platform helps customers discover optimization paths, reduce costs, and predict deviations in manufacturing systems. Aizon announced it closed a $20 million Series C to scale operations and accelerate its development pipeline. The company said the new capital will help accelerate the launch of its eBR solution in Q3 2024 and better serve its customers. Existing investors Atlantic Bridge, Crosslink Capital, and Uncork Capital remain supporters alongside the new lead investor. Bigfinite offers an AI-powered SaaS analytics platform that integrates unlimited structured and unstructured manufacturing data to deliver real-time visibility and predictive insights for regulated industries. The platform emphasizes GxP-compliant data integrity and predictive models to reduce quality issues and optimize manufacturing processes. The company positions its solution for pharmaceutical and biotech manufacturers seeking to improve compliance and operational efficiency. The new funding is intended to support market expansion of Bigfinite’s SaaS platform. Bigfinite has raised institutional backing from strategic investors and reported total funding to date of more than $23.5 million. The company was founded in 2014 and is based in San Francisco with a European office in Barcelona. Bigfinite provides data analytics and AI solutions to optimize pharmaceutical manufacturing processes. Its Bigengine SaaS platform helps pharma companies discover ways to optimize processes, reduce quality issues, and enhance regulatory compliance. The company launched Bigengine v1.5, which includes a drag-and-drop solutions editor and five new solutions: Predictive Maintenance, Predictive OEE, Golden Batch, Energy efficiency and Causality Detection. Founded in 2013 by Pep Gubau, Bigfinite operates from offices in San Francisco and Barcelona and had 32 employees at the time of the article. The company expected to double its headcount by the end of Q2 2018. It plans to use the new capital to expand business development and customer support.

Team

No current team members are available.